VIVS:NASDAQVivoSim Labs, Inc. Analysis

VivoSim Labs is trading at $1.39, which sits below its 20‑day ($1.467) and 50‑day ($1.635) simple moving averages, confirming a bearish price pattern. The 14‑day RSI of 37 suggests the stock is approaching oversold territory, while the MACD line has just crossed above its signal, offering a faint bullish hint. Volume is on an increasing trend, but the 30‑day volatility of over 77% and a beta of 0.5 underscore a highly erratic price environment. Fundamentally, the company posted an 8.3% revenue growth year‑over‑year, and recent news cites a 16% revenue lift from the integration of The Sleep Center of Nevada. However, operating margins are deeply negative (‑105%), cash flow is strongly negative, and the balance sheet shows a modest cash cushion of $4.3 M against $0.8 M of debt. Despite an ultra‑low trailing PE of 0.79 versus a sector average of 26.4, the high price‑to‑sales multiple (≈28×) and ongoing cash burn keep the upside constrained.